Showing results (741-750 of 23,394) with videos related to
Sort By:
Pageof 2,340
DNA (Mary Ann Liebert, Inc.)|October 1, 1986
Molecular cloning and expression in Escherichia coli of equine type I interferonsA Himmler, R Hauptmann, G R Adolf, et al.Frontiers in Neuroengineering|October 19, 2011
Modified pulse shapes for effective neural stimulationLorenz Hofmann, Martin Ebert, Peter Alexander Tass, et al.Frontiers in Neuroengineering|December 14, 2011
Modeling of a segmented electrode for desynchronizing deep brain stimulationJ Buhlmann, L Hofmann, P A Tass, et al.Biomedica Biochimica Acta|January 1, 1983
Comparative study on the antithrombotic effects of a synthetic thrombin inhibitor and of heparin in animal modelsJ Hauptmann, A Barth, F P Schönberger, et al.Clinical and Experimental Immunology|September 1, 1979
Acquired C1 inhibitor deficiency in a case of lymphosarcoma of the spleen. Reversal of complement abnormalities after splenectomyG Hauptmann, F Petitjean, J M Lang, et al.Pathology, Research and Practice|December 22, 1999
Telomerase activity in benign bone tumors and tumor-like lesionsA Kido, R Schneider-Stock, K Hauptmann, et al.Bioconjugate Chemistry|July 18, 2000
Concepts for the syntheses of biotinylated steroids. Part II: 17beta-estradiol derivatives as immunochemical probesH Hauptmann, B Paulus, T Kaiser, et al.Human Genetics|April 7, 1977
Bf polymorphism: another variant (S0.8)G Hauptmann, E Wertheimer, M M Tongio, et al.Immunology|March 1, 1991
Inhibition of tumour necrosis factor alpha (TNF-alpha)-induced neutrophil respiratory burst by a TNF inhibitorA Ferrante, B Hauptmann, P Seckinger, et al.Annales Francaises D'Anesthesie Et De Reanimation|January 1, 1985
[Drugs inhibiting complement activation]G Hauptmann, J Goetz, A Steib, et al.Pageof 2,340